We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
19/7/2017 15:02 | Hopefully this one has made its mind up now and finished faffing around at 1590/1600p support, buyers coming in ahead of ex div in 3 weeks. Back to 1715p before long. | ny boy | |
19/7/2017 13:19 | GlaxoSmithKline plc (LON:GSK) is reportedly mulling the sale of its Horlicks malted milk drink business in the UK as part of its plans to prioritise the drugs division. The pharmaceuticals giant will offload Horlicks, which is marketed as a nutritional drink, in the UK but will keep it in India, according to the BBC. Chief executive Emma Walmsley, who took over the reins from Sir Andrew Witty in April, said she wanted to focus on the company’s drugs business when she revealed her first set of results as boss earlier this year. "I want to make that more at the heart of where we spend our leadership time and what we spend our time talking about," she said at the time. Proactiveinvestors.c | philanderer | |
19/7/2017 09:25 | Bonty..you just called it lower, so you could make a timely purchase sub 1600p ..as tomorrow we are only 3 weeks away from ex div.(10August) Buyers will come in over the next few weeks, especially as the share price has fallen 100p approx | ny boy | |
18/7/2017 22:01 | EssentialThat was some fire. | montyhedge | |
18/7/2017 12:18 | Oh dear, the health postcode lottery. I am sorry to see the good people of Surrey so cruelly discriminated against. | grahamite2 | |
18/7/2017 12:12 | No,I mean 1590p is an important chart support on the long term chart. | ny boy | |
18/7/2017 10:09 | As the local health centre in Weybridge burnt to the ground last week, seeing a Dr is a challenge ATM!. Monty lives in the same area. | essentialinvestor | |
18/7/2017 10:00 | 18 Jul '17 - 08:47 - 14531 of 14536 0 0 1510p on the cards, Novartis disappointed. Sentiment changing for the pharma's, rotation to take place.Monty your a diamond.Keep posting utter rubbish.Because when you post this drivel the share price goes in the opposite direction.PFC,and VOD come to mind.Remember.Keep taking the tablets.Better still get your Doctor to increase your dosage !!! | garycook | |
18/7/2017 09:58 | Well, intra-day that is. Best see what the 2-3 consecutive closing prices are .... ;0) | tradermichael | |
18/7/2017 09:45 | First test of 1590p support! | ny boy | |
18/7/2017 09:29 | It's mainly rotation out of Pharma's. Looks like into tech. | montyhedge | |
18/7/2017 09:05 | NOVN up about 2% atm. | essentialinvestor | |
18/7/2017 09:04 | US$ @ 1.31 this morning. | alphorn | |
18/7/2017 09:01 | Monty, with the strategic review who knows. | essentialinvestor | |
18/7/2017 08:47 | 1510p on the cards, Novartis disappointed. Sentiment changing for the pharma's, rotation to take place. | montyhedge | |
18/7/2017 06:27 | Expected market weakness over May/June, there was I waiting at the church ). | essentialinvestor | |
16/7/2017 09:25 | The influence of overseas drugs giants in the UK healthcare system could come under scrutiny after it emerged that foreign firms are the driving force behind a judicial review challenge to new NHS drug pricing powers. Sunday Telegraph | philanderer | |
15/7/2017 12:39 | Decisions, decisions. There is a 21 month long upward trending support line on the chart which stands at around 1560 (and rising, of course) just now. I would be thinking a lot about what to do, if it broke down through that trend line. Cross that bridge whwn we get to it. | solomon | |
15/7/2017 11:43 | I'm in two minds whether to get back in. Being in the same position as before, except £1 cheaper, can't be bad. On the other hand I sold in the first place against the likelihood of a general pullback in the market. | grahamite2 | |
15/7/2017 10:54 | Down, up, down ..a bit wobbly,stronger £ not helping | ny boy | |
14/7/2017 17:50 | EI - LOL's! | alphorn | |
14/7/2017 14:00 | On the rise again! | ny boy | |
14/7/2017 11:18 | It's largely down to how the strategic update is viewed, anyone's guess. Alp, very witty!. | essentialinvestor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions